{
    "clinical_study": {
        "@rank": "161609", 
        "arm_group": [
            {
                "arm_group_label": "remifentanil group", 
                "arm_group_type": "Experimental", 
                "description": "Remifentanil 0.05 ug/kg/min is infused to the patients."
            }, 
            {
                "arm_group_label": "control", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Normal saline 0.2 ml/kg/hour is infused to the patients"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the present study is to assess the effect of postoperative remifentanil infusion\n      on the incidence of emergence agitation in preschool-aged children undergoing strabismus\n      surgery with sevoflurane anaesthesia."
        }, 
        "brief_title": "The Effect of Remifentanil Infusion During Emergence on the Incidence of Emergence Delirium", 
        "completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Delirium", 
        "condition_browse": {
            "mesh_term": "Delirium"
        }, 
        "detailed_description": {
            "textblock": "Patients are randomly assigned to one of two groups. Anesthesia is maintained with\n      sevoflurane and remifentanil infusion. All patients received a predetermined concentrations\n      of remifentanil according to their group assignments (control group, remifentanil 0\n      ug/kg/min; remifentanil group, remifentanil 0.05 ug/kg/min) from 10 minutes before the end\n      of surgery to discharge from postanesthetic care unit. emergence agitation is assessed\n      during the emergence phase."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  American Society of Anesthesiologists physical status I and II\n\n          -  preschool-aged children undergoing strabismus surgery\n\n        Exclusion Criteria:\n\n          -  psychological disorders\n\n          -  emotional disorders\n\n          -  abnormal cognitive development\n\n          -  developmental delay\n\n          -  allergy to the drugs in our protocol"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "7 Years", 
            "minimum_age": "3 Years"
        }, 
        "enrollment": {
            "#text": "86", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 31, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02108795", 
            "org_study_id": "apsj20140331"
        }, 
        "intervention": [
            {
                "arm_group_label": "remifentanil group", 
                "description": "Children randomised to remifentanil group receive remifentanil 0.05 ug/kg/min. Children randomised to control group receive normal saline (placebo)", 
                "intervention_name": "Remifentanil", 
                "intervention_type": "Drug", 
                "other_name": "remifentanil (ultiva)"
            }, 
            {
                "arm_group_label": "control", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Remifentanil"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 8, 2014", 
        "location": {
            "contact": {
                "email": "apsj0718@naver.com", 
                "last_name": "Duckhee Lee, M.D.", 
                "phone": "82-53-620-3365"
            }, 
            "facility": {
                "address": {
                    "city": "Daegu", 
                    "country": "Korea, Republic of", 
                    "zip": "705-035"
                }, 
                "name": "Department of Anesthesiology and Pain Medicine, Yeungnam University hospital"
            }, 
            "investigator": {
                "last_name": "Sangjin Park, M.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of Remifentanil Infusion During Emergence on the Incidence of Emergence Delirium After Sevoflurane Anesthesia in Pediatric Strabismus Surgery", 
        "overall_contact": {
            "email": "apsj0718@naver.com", 
            "last_name": "Sangjin Park, M.D.", 
            "phone": "82-53-620-3366"
        }, 
        "overall_official": {
            "affiliation": "Department of Anesthesiology and Pain Medicine, College of medicine, Yeungnam University, Daemyung-Dong, Nam-Gu, Daegu, Republic of Korea", 
            "last_name": "Sangjin Park, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "A blinded observer record emergence agitation at just after laryngeal mask removal, 5 minutes after arrival in postanesthetic care unit, 10 minutes after arrival in postanesthetic care unit, 15 minutes after arrival in postanesthetic care unit, 30 minutes after arrival in postanesthetic care unit, and 30 minutes after discharge from postanesthetic care unit.", 
            "measure": "the scale of emergence agitation", 
            "safety_issue": "Yes", 
            "time_frame": "up to 30 minutes after arrival in postanesthetic care unit, and 30 minutes after discharge from postanesthetic care unit."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02108795"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Yeungnam University College of Medicine", 
            "investigator_full_name": "Sangjin Park", 
            "investigator_title": "assistant professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "A blinded observer record duration of anaesthesia, eye-opening time, time to remove laryngeal mask airway, respiratory depression, nausea, and vomiting at the end of surgery, 5 minutes after arrival in postanesthetic care unit, 10 minutes after arrival in postanesthetic care unit, 15 minutes after arrival in postanesthetic care unit, 30 minutes after arrival in postanesthetic care unit, and 30 minutes after discharge from postanesthetic care unit.", 
            "measure": "the effect of remifentanil on the emergence", 
            "safety_issue": "Yes", 
            "time_frame": "up to 30 minutes after the discharge form postanesthetic care unit"
        }, 
        "source": "Yeungnam University College of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yeungnam University College of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}